Logo image of IXX.DE

INIT INNOVATION IN TRAFFIC S (IXX.DE) Stock Fundamental Analysis

FRA:IXX - Deutsche Boerse Ag - DE0005759807 - Common Stock - Currency: EUR

37  +0.9 (+2.49%)

Fundamental Rating

5

Taking everything into account, IXX scores 5 out of 10 in our fundamental rating. IXX was compared to 101 industry peers in the Software industry. IXX has only an average score on both its financial health and profitability. IXX is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year IXX was profitable.
In the past year IXX had a positive cash flow from operations.
Each year in the past 5 years IXX has been profitable.
IXX had a positive operating cash flow in each of the past 5 years.
IXX.DE Yearly Net Income VS EBIT VS OCF VS FCFIXX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

IXX has a Return On Assets of 4.57%. This is in the better half of the industry: IXX outperforms 62.75% of its industry peers.
IXX's Return On Equity of 10.96% is fine compared to the rest of the industry. IXX outperforms 70.59% of its industry peers.
IXX has a better Return On Invested Capital (9.38%) than 74.51% of its industry peers.
IXX had an Average Return On Invested Capital over the past 3 years of 9.12%. This is in line with the industry average of 11.09%.
The last Return On Invested Capital (9.38%) for IXX is above the 3 year average (9.12%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.57%
ROE 10.96%
ROIC 9.38%
ROA(3y)5.83%
ROA(5y)5.96%
ROE(3y)12.79%
ROE(5y)13.4%
ROIC(3y)9.12%
ROIC(5y)9.1%
IXX.DE Yearly ROA, ROE, ROICIXX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of IXX (5.12%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of IXX has declined.
IXX's Operating Margin of 8.92% is fine compared to the rest of the industry. IXX outperforms 63.73% of its industry peers.
IXX's Operating Margin has been stable in the last couple of years.
IXX has a Gross Margin of 36.42%. This is in the lower half of the industry: IXX underperforms 74.51% of its industry peers.
IXX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.92%
PM (TTM) 5.12%
GM 36.42%
OM growth 3Y0.63%
OM growth 5Y-0.77%
PM growth 3Y-6.08%
PM growth 5Y-4.28%
GM growth 3Y1.46%
GM growth 5Y1.73%
IXX.DE Yearly Profit, Operating, Gross MarginsIXX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IXX is creating some value.
IXX has more shares outstanding than it did 1 year ago.
IXX has less shares outstanding than it did 5 years ago.
IXX has a worse debt/assets ratio than last year.
IXX.DE Yearly Shares OutstandingIXX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
IXX.DE Yearly Total Debt VS Total AssetsIXX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

IXX has an Altman-Z score of 3.12. This indicates that IXX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.12, IXX is in line with its industry, outperforming 51.96% of the companies in the same industry.
A Debt/Equity ratio of 0.38 indicates that IXX is not too dependend on debt financing.
IXX has a Debt to Equity ratio (0.38) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 3.12
ROIC/WACC1.29
WACC7.29%
IXX.DE Yearly LT Debt VS Equity VS FCFIXX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.56 indicates that IXX should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.56, IXX is doing good in the industry, outperforming 62.75% of the companies in the same industry.
IXX has a Quick Ratio of 1.10. This is a normal value and indicates that IXX is financially healthy and should not expect problems in meeting its short term obligations.
IXX has a Quick ratio of 1.10. This is comparable to the rest of the industry: IXX outperforms 42.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.1
IXX.DE Yearly Current Assets VS Current LiabilitesIXX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

7

3. Growth

3.1 Past

IXX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.61%.
Measured over the past 5 years, IXX shows a small growth in Earnings Per Share. The EPS has been growing by 6.71% on average per year.
The Revenue has grown by 28.24% in the past year. This is a very strong growth!
The Revenue has been growing by 11.17% on average over the past years. This is quite good.
EPS 1Y (TTM)-23.61%
EPS 3Y7.84%
EPS 5Y6.71%
EPS Q2Q%-35.16%
Revenue 1Y (TTM)28.24%
Revenue growth 3Y14.57%
Revenue growth 5Y11.17%
Sales Q2Q%39.55%

3.2 Future

IXX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.07% yearly.
The Revenue is expected to grow by 16.08% on average over the next years. This is quite good.
EPS Next Y14.53%
EPS Next 2Y23.54%
EPS Next 3Y25.07%
EPS Next 5YN/A
Revenue Next Year21.36%
Revenue Next 2Y18.63%
Revenue Next 3Y16.93%
Revenue Next 5Y16.08%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IXX.DE Yearly Revenue VS EstimatesIXX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M
IXX.DE Yearly EPS VS EstimatesIXX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.83, IXX is valued on the expensive side.
IXX's Price/Earnings ratio is rather cheap when compared to the industry. IXX is cheaper than 85.29% of the companies in the same industry.
When comparing the Price/Earnings ratio of IXX to the average of the S&P500 Index (27.45), we can say IXX is valued inline with the index average.
With a Price/Forward Earnings ratio of 13.96, IXX is valued correctly.
IXX's Price/Forward Earnings ratio is rather cheap when compared to the industry. IXX is cheaper than 85.29% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, IXX is valued a bit cheaper.
Industry RankSector Rank
PE 24.83
Fwd PE 13.96
IXX.DE Price Earnings VS Forward Price EarningsIXX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IXX is valued a bit cheaper than the industry average as 77.45% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.71
IXX.DE Per share dataIXX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
IXX has a very decent profitability rating, which may justify a higher PE ratio.
IXX's earnings are expected to grow with 25.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.71
PEG (5Y)3.7
EPS Next 2Y23.54%
EPS Next 3Y25.07%

5

5. Dividend

5.1 Amount

IXX has a Yearly Dividend Yield of 2.22%.
Compared to an average industry Dividend Yield of 2.13, IXX pays a better dividend. On top of this IXX pays more dividend than 93.14% of the companies listed in the same industry.
IXX's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.22%

5.2 History

The dividend of IXX is nicely growing with an annual growth rate of 39.51%!
Dividend Growth(5Y)39.51%
Div Incr Years3
Div Non Decr Years6
IXX.DE Yearly Dividends per shareIXX.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

IXX pays out 47.27% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of IXX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP47.27%
EPS Next 2Y23.54%
EPS Next 3Y25.07%
IXX.DE Yearly Income VS Free CF VS DividendIXX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M
IXX.DE Dividend Payout.IXX.DE Dividend Payout, showing the Payout Ratio.IXX.DE Dividend Payout.PayoutRetained Earnings

INIT INNOVATION IN TRAFFIC S

FRA:IXX (7/4/2025, 7:00:00 PM)

37

+0.9 (+2.49%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-15 2025-05-15
Earnings (Next)08-14 2025-08-14
Inst Owners14.48%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap371.48M
Analysts83.33
Price Target57.12 (54.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.22%
Yearly Dividend0.7
Dividend Growth(5Y)39.51%
DP47.27%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.66%
Valuation
Industry RankSector Rank
PE 24.83
Fwd PE 13.96
P/S 1.3
P/FCF N/A
P/OCF 19.67
P/B 2.78
P/tB 4.98
EV/EBITDA 10.71
EPS(TTM)1.49
EY4.03%
EPS(NY)2.65
Fwd EY7.17%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)1.88
OCFY5.08%
SpS28.45
BVpS13.29
TBVpS7.43
PEG (NY)1.71
PEG (5Y)3.7
Profitability
Industry RankSector Rank
ROA 4.57%
ROE 10.96%
ROCE 12.58%
ROIC 9.38%
ROICexc 10.76%
ROICexgc 16.15%
OM 8.92%
PM (TTM) 5.12%
GM 36.42%
FCFM N/A
ROA(3y)5.83%
ROA(5y)5.96%
ROE(3y)12.79%
ROE(5y)13.4%
ROIC(3y)9.12%
ROIC(5y)9.1%
ROICexc(3y)10.98%
ROICexc(5y)11.12%
ROICexgc(3y)15.05%
ROICexgc(5y)15.07%
ROCE(3y)12.24%
ROCE(5y)12.21%
ROICexcg growth 3Y4.46%
ROICexcg growth 5Y0.68%
ROICexc growth 3Y0.88%
ROICexc growth 5Y-2.8%
OM growth 3Y0.63%
OM growth 5Y-0.77%
PM growth 3Y-6.08%
PM growth 5Y-4.28%
GM growth 3Y1.46%
GM growth 5Y1.73%
F-Score5
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 1.26
Cap/Depr 128.39%
Cap/Sales 6.86%
Interest Coverage 36.67
Cash Conversion 46.33%
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.1
Altman-Z 3.12
F-Score5
WACC7.29%
ROIC/WACC1.29
Cap/Depr(3y)112.24%
Cap/Depr(5y)90.28%
Cap/Sales(3y)5.99%
Cap/Sales(5y)4.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.61%
EPS 3Y7.84%
EPS 5Y6.71%
EPS Q2Q%-35.16%
EPS Next Y14.53%
EPS Next 2Y23.54%
EPS Next 3Y25.07%
EPS Next 5YN/A
Revenue 1Y (TTM)28.24%
Revenue growth 3Y14.57%
Revenue growth 5Y11.17%
Sales Q2Q%39.55%
Revenue Next Year21.36%
Revenue Next 2Y18.63%
Revenue Next 3Y16.93%
Revenue Next 5Y16.08%
EBIT growth 1Y2.47%
EBIT growth 3Y15.3%
EBIT growth 5Y10.31%
EBIT Next Year76.79%
EBIT Next 3Y37.01%
EBIT Next 5YN/A
FCF growth 1Y-104.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.28%
OCF growth 3Y-12.18%
OCF growth 5Y-12.5%